CD20-targeting CAR T cell therapy based on rituximab for the treatment of CD19-negative B cell malignancies
2020
CD20-targeting CAR T cell therapy based on rituximab for the treatment of CD19-negative B cell malignancies
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI